|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 |
| (11) | Number of the document | 2824181 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13757006.5 |
| Date of filing the European patent application | 2013-03-07 | |
| (97) | Date of publication of the European application | 2015-01-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2013/056225 |
| Date | 2013-03-07 |
| (87) | Number | WO 2013/133351 |
| Date | 2013-09-12 |
| (30) | Number | Date | Country code |
| 2012052147 | 2012-03-08 | JP | |
| 2012195451 | 2012-09-05 | JP | |
| 2012280325 | 2012-12-21 | JP |
| (72) |
SUZUKI, Atsushi, JP
ASAUMI, Makoto, JP
TSUNOYAMA, Kazuhisa, JP
NISHIMURA, Kouichi, JP
MORINAKA, Akifumi, JP
YAMAUCHI, Tomohiro, JP
YOSHINO, Masayasu, JP
YOSHIZAKI, Hiroaki, JP
|
| (73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411,
JP
|
| (54) | NOVEL FGFR3 FUSION PRODUCT |
| NOVEL FGFR3 FUSION PRODUCT |